Patents by Inventor Heinz Peter Vollmers

Heinz Peter Vollmers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
    Patent number: 9783599
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 10, 2017
    Assignee: Patrys Limited
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Andreas Thalheimer, Leodevico L. Ilag, Barbara E. Power, Lishanthi Udabage, Frank Hensel, Frank Schoenen, Arndt-Rene Kelter, Christopher Garth Hosking
  • Human monoclonal antibody having fat-reducing effect
    Patent number: 9273125
    Abstract: Purified polypeptide is proposed, the amino acid sequence of which is essentially identical to the amino acid sequence of SEQ ID NO:1 and SEQ ID NO:3, the polypeptide binding low density lipoproteins (LDL) and/or oxidized LDL (oxLDL), in particular LDL cholesterol and/or oxidized LDL cholesterol (oxLDL cholesterol). The invention includes the use of the polypeptide in combination with conventional adjuvants and/or carrier substances for producing a drug having a fat-reducing effect and for producing drugs for treating renal diseases.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: March 1, 2016
    Assignee: Patrys Limited
    Inventor: Heinz Peter Vollmers
  • LM-Antibodies, Functional Fragments, LM-1 Target Antigen, and Methods for Making and Using Same
    Publication number: 20150071931
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: March 14, 2014
    Publication date: March 12, 2015
    Applicant: Patrys Limited
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Andreas Thalheimer, Leodevico L. Ilag, Barbara E. Power, Lishanthi Udabage, Frank Hensel, Frank Schoenen, Arndt-Rene Kelter, Christopher Garth Hosking
  • Adenocarcinoma specific antibody SAM-6, and uses thereof
    Patent number: 8741296
    Abstract: The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: June 3, 2014
    Assignee: Patrys Limited
    Inventors: Heinz Peter Vollmers, Hans-Konrad Müller-Hermelink
  • Neoplasm specific antibodies and uses thereof
    Patent number: 8562995
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: October 22, 2013
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Müeller-Hermelink, Heinz Peter Vollmers
  • NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS
    Publication number: 20130101588
    Abstract: The invention provides polypeptide, nucleic acid and other compositions. Polypeptide, nucleic acid and other compositions are useful in treatment and diagnostic methods. One treatment method includes inhibiting growth or proliferation of hyperproliferative cells or inducing regression of hyperproliferative cells, such as cells of a cellular hyperproliferative disorder, or reducing levels of LDL or oxLDL.
    Type: Application
    Filed: August 2, 2010
    Publication date: April 25, 2013
    Applicant: PATRYS LIMITED
    Inventor: Heinz Peter Vollmers
  • HUMAN MONOCLONAL ANTIBODY HAVING FAT-REDUCING EFFECT
    Publication number: 20130072664
    Abstract: Purified polypeptide is proposed, the amino acid sequence of which is essentially identical to the amino acid sequence of SEQ ID NO:1 and SEQ ID NO:3, the polypeptide binding low density lipoproteins (LDL) and/or oxidized LDL (oxLDL), in particular LDL cholesterol and/or oxidized LDL cholesterol (oxLDL cholesterol). The invention includes the use of the polypeptide in combination with conventional adjuvants and/or carrier substances for producing a drug having a fat-reducing effect and for producing drugs for treating renal diseases.
    Type: Application
    Filed: February 27, 2012
    Publication date: March 21, 2013
    Applicant: PATRYS LIMITED
    Inventor: HEINZ PETER VOLLMERS
  • Human monoclonal antibody having fat-reducing effect
    Patent number: 8124080
    Abstract: A purified polypeptide having an amino acid sequence that is substantial identical with the amino acid sequence of SEQ ID NO:1, SEQ ID NO:3, or both, in which the polypeptide binds low density lipoproteins (LDL) or oxidized LDL (oxLDL), or both, and particularly binds well to LDL cholesterol and oxidized LDL cholesterol. The polypeptide may be used in combination with conventional adjuvants or carrier substances for producing a drug having a fat-reducing effect and for producing drugs for aiding in the treatment of renal diseases.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: February 28, 2012
    Assignee: Patrys Limited
    Inventor: Heinz Peter Vollmers
  • NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20110287021
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: May 19, 2011
    Publication date: November 24, 2011
    Applicant: PATRYS LIMITED
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Peter Vollmers
  • Neoplasm specific antibodies and uses thereof
    Patent number: 7947812
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: May 24, 2011
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Peter Vollmers
  • NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20110076763
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: August 17, 2010
    Publication date: March 31, 2011
    Applicant: PATRYS LIMITED
    Inventors: HEINZ PETER VOLLMERS, Hans Konrad Mueller-Hermelink
  • SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS
    Publication number: 20110027182
    Abstract: The invention relates to a substance and a process for obtaining anti-tumor agents.
    Type: Application
    Filed: July 1, 2010
    Publication date: February 3, 2011
    Inventors: Heinz-Peter Vollmers, Hans Konrad Mueller-Hermelink, Annette Buechner-Vollmers
  • LM-1 ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME
    Publication number: 20100322936
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 23, 2010
    Applicant: PATRYS LIMITED
    Inventors: HEINZ PETER VOLLMERS, STEPHANIE UTE BRANDLEIN, ANDREAS THALHEIMER, LEODEVICO L. ILAG, BARBARA E. POWER, LISHANTHI UDABAGE, FRANK HENSEL, FRANK SCHOENEN, ARNDT-RENE KELTER, CHRISTOPHER GARTH HOSKING
  • ANTI-IDIOTYPE ANTIBODIES OF THE HUMAN MONOCLONAL ANTIBODY SC-1, AND THEIR PRODUCTION AND USE
    Publication number: 20100316630
    Abstract: The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies.
    Type: Application
    Filed: November 3, 2009
    Publication date: December 16, 2010
    Inventors: HEINZ PETER VOLLMERS, HANS KONRAD MÜLLER-HERMELINK
  • Substance for obtaining highly effective tumor medications as well as a process
    Patent number: 7767787
    Abstract: The invention relates to a substance and a process for obtaining anti-tumor agents.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: August 3, 2010
    Assignee: Debiovision Inc.
    Inventors: Heinz Peter Vollmers, Hans Konrad Mueller-Hermelink
  • Neoplasm specific antibodies and uses thereof
    Patent number: 7741444
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: June 22, 2010
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Peter Vollmers
  • BARB4 TARGET, ANTIBODY DESIGNATED BARB4, BARB4 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME
    Publication number: 20090291083
    Abstract: The invention provides antibodies, functional fragments, modified and variant forms, antibody targets, nucleic acid and other compositions. Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment, diagnostic and vaccination methods. One treatment method includes inhibiting growth or proliferation of proliferating cells, such as hyperproliferative cells or inducing regression of hyperproliferative cells, such as cells of a cellular hyperproliferative disorder.
    Type: Application
    Filed: January 7, 2009
    Publication date: November 26, 2009
    Applicant: PATRYS LIMITED
    Inventors: Heinz Peter Vollmers, Stephanie ute Brandlein, Leodevico L. Ilag, Barbara Power, Frank Hensel
  • Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use
    Patent number: 7611894
    Abstract: The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: November 3, 2009
    Assignee: Debiovision
    Inventors: Heinz Peter Vollmers, Hans Konrad Müller-Hermelink
  • ANTIBODY DESIGNATED BARB3, BARB3 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME
    Publication number: 20090258020
    Abstract: The invention provides antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One treatment method includes inhibiting growth or proliferation of proliferating cells, such as hyperproliferative cells or inducing regression of hyperproliferative cells, such as cells of a cellular hyperproliferative disorder.
    Type: Application
    Filed: January 6, 2009
    Publication date: October 15, 2009
    Applicant: PATRYS LIMITED
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Frank Hensel
  • Neoplasm-specific polypeptides and their uses
    Publication number: 20090136420
    Abstract: The present invention features novel polypeptides and methods of using these polypeptides in the diagnosis, detection, monitoring, and treatment of neoplasms in a mammal, e.g., a human.
    Type: Application
    Filed: May 27, 2008
    Publication date: May 28, 2009
    Applicant: Debiovision, Inc.
    Inventors: Hans Konrad Muller-Hermelink, Heinz Peter Vollmers, Frank Hensel